Cargando…

Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease

The prognosis of microscopic polyangiitis (MPA) with interstitial lung disease (ILD) is significantly worse than that of MPA without ILD. However, the clinical characteristics in MPA-ILD, especially poor prognostic factors, are not elucidated. We evaluated demographic, clinical, laboratory, and radi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuda, Shogo, Kotani, Takuya, Suzuka, Takayasu, Kiboshi, Takao, Fukui, Keisuke, Wakama, Minako, Ishida, Takaaki, Fujiki, Youhei, Shiba, Hideyuki, Nagai, Koji, Hata, Kenichiro, Shoda, Takeshi, Ito, Yuri, Makino, Shigeki, Takeuchi, Tohru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810976/ https://www.ncbi.nlm.nih.gov/pubmed/33452394 http://dx.doi.org/10.1038/s41598-021-81311-7

Ejemplares similares

Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
por: Matsuda, Shogo, et al.
Publicado: (2023)

Association between Serum Biomarkers and Peripheral Neuropathy in Microscopic Polyangiitis
por: Masuda, Yuichi, et al.
Publicado: (2022)

Pre-Treatment Ferritin Level and Alveolar-Arterial Oxygen Gradient Can Predict Mortality Rate Due to Acute/Subacute Interstitial Pneumonia in Dermatomyositis Treated by Cyclosporine A/Glucocorticosteroid Combination Therapy: A Case Control Study
por: Isoda, Kentaro, et al.
Publicado: (2014)

Increased Serum LIGHT Levels Correlate with Disease Progression and Severity of Interstitial Pneumonia in Patients with Dermatomyositis: A Case Control Study
por: Kotani, Takuya, et al.
Publicado: (2015)

Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan
por: Sugiyama, Koichi, et al.
Publicado: (2012)

Risk prediction model for mortality in microscopic polyangiitis: multicentre REVEAL cohort study
por: Kotani, Takuya, et al.
Publicado: (2023)

Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study
por: Oda, Katsuhiro, et al.
Publicado: (2017)

Publisher Correction: Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia
por: Kotani, Takuya, et al.
Publicado: (2018)

Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia
por: Kotani, Takuya, et al.
Publicado: (2017)

Publisher Correction: Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia
por: Kotani, Takuya, et al.
Publicado: (2018)

Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis
por: Tokai, Nao, et al.
Publicado: (2018)

Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis
por: Tokai, Nao, et al.
Publicado: (2019)

Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus
por: Hiramatsu, Yuri, et al.
Publicado: (2021)

Low-Molecular-Weight Heparin Enhanced Therapeutic Effects of Human Adipose-Derived Stem Cell Administration in a Mouse Model of Lupus Nephritis
por: Matsuda, Shogo, et al.
Publicado: (2022)

Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
por: Suzuka, Takayasu, et al.
Publicado: (2022)

Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis
por: Harigai, Masayoshi, et al.
Publicado: (2019)

Microscopic Polyangiitis in Systemic Sclerosis
por: Hashimoto, Hiroshi
Publicado: (2010)

Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study
por: Sada, Ken-ei, et al.
Publicado: (2015)

Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab
por: Geetha, Duvuru, et al.
Publicado: (2014)

Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
por: Shah, Shivani, et al.
Publicado: (2015)

Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis
por: Merkel, Peter A., et al.
Publicado: (2021)

Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis
por: Samson, Maxime, et al.
Publicado: (2023)

Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis
por: Villeneuve, Thomas, et al.
Publicado: (2023)

Correlation of increased serum leucine-rich α2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective study
por: Ishida, Takaaki, et al.
Publicado: (2020)

Microscopic polyangiitis associated with thymic tumor: a case report and review of the literature
por: Miyamoto, Yasunori, et al.
Publicado: (2019)

Deep vein thrombosis: An unusual way of revealing microscopic polyangiitis. Deep vein thrombosis in microscopic polyangiitis
por: Jerbi, Mouna, et al.
Publicado: (2020)

Microscopic polyangiitis associated with subarachnoid hemorrhage
por: Ihara, Katsuhito, et al.
Publicado: (2019)

Microscopic Polyangiitis Initially Presumed to Be Endocarditis
por: Kaneko, Takahiro, et al.
Publicado: (2020)

Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis
por: Iudici, Michele, et al.
Publicado: (2016)

The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis
por: Pyo, Jung Yoon, et al.
Publicado: (2021)

Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis
por: Ahn, Sung Soo, et al.
Publicado: (2021)

Clinical Features and Outcomes of Microscopic Polyangiitis in Korea
por: Oh, Ji Seon, et al.
Publicado: (2009)

Paraneoplastic microscopic polyangiitis presenting after thymectomy
por: Tracey, Elisabeth H., et al.
Publicado: (2016)

The Clinical and Pathological Features of Children With Microscopic Polyangiitis
por: Li, Qian, et al.
Publicado: (2021)

Tozinameran: Relapse of microscopic polyangiitis: case report
Publicado: (2021)

Serum 20S proteasome levels are associated with disease activity in MPO-ANCA-associated microscopic polyangiitis
por: Maruyama, Hiroshi, et al.
Publicado: (2020)

Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis
por: Deshayes, Samuel, et al.
Publicado: (2018)

Clinical characteristics of patients with granulomatosis with polyangiitis and microscopic polyangiitis in ENT practice: a comparative analysis
por: WOJCIECHOWSKA, J., et al.
Publicado: (2018)

Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator
por: Kwon, Hyeok Chan, et al.
Publicado: (2020)

Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report
por: Ide, Hiroyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9pi9kkstrsvhahtis8e39krimp